Co-developed by NYU Langone and Dana-Farber, the Solavia platform integrates EHR workflows, decision support, and pathway tracking for APPs and PAs.
|Articles|August 17, 2015
Shelagh Wright Discusses Challenges in Pain Management
Author(s)Shelagh Wright, PhD
Shelagh Wright, PhD, a retired lecturer in psycho-oncology, Dublin City University, discusses challenges for nurses in pain management.
Advertisement
Shelagh Wright, PhD, a retired lecturer in psycho-oncology, Dublin City University, discusses challenges for nurses in pain management.
Advertisement
Related to this article
The FDA expands accelerated approval for sevabertinib to frontline HER2-mutant NSCLC, highlighting a need for vigilant nursing management of diarrhea.
FDA approves camizestrant for ESR1-mutated advanced breast cancer, tasking oncology nurses with guiding patients through ctDNA-based surveillance.
Dana Delaski, MSN, FNP-BC, shares insights on how once-daily ruxolitinib, self-injected rusfertide, and givinostat will transform PV clinic workflows.
The FDA has approved oral iberdomide (Zenbexus) for relapsed/refractory multiple myeloma, offering patients a highly potent, accessible therapy.
Oncology clinicians must actively champion NCCN guidelines as a critical pillar of breast cancer survivorship care,
With daraxonrasib approved for metastatic pancreatic cancer, Yolanda Justal, APRN, discusses essential nursing workflows for home-based care.
Beth Sandy, CRNP, of Penn Medicine explains how oncology nurses and pharmacists collaborate to manage financial toxicity and secure oral therapies.
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Oncology Experts Discuss On-Body Subcutaneous Isatuximab in Multiple Myeloma
2
Why Using AI to Interpret Mammogram Results Can Cause Unnecessary Panic
3
KEYNOTE-564 5-Year Data: Adjuvant Pembrolizumab Benefits ccRCC
4
Updated ASTRO Pancreatic Guidelines: Key Takeaways for Oncology Nurses
5